iPSC CAR-NK cell therapy / MARU Therap - LARVOL DELTA

Maru Therapeutics 'iPSC CAR-NK treatment effective against glioblastoma' [Google translation] (HIT News) - "Maru Therapeutics...announced on the 22nd that the induced pluripotent stem cell (iPSC)-based CAR-NK treatment being developed in-house confirmed a significant tumor reduction effect in an animal efficacy test for glioblastoma...In a study conducted jointly with Seoul National University, Maru Therapeutics injected CAR-NK cells into mice transplanted with glioblastoma containing human blood vessels (GBVA) and confirmed that the size of the tumor was significantly reduced compared to the control group. Based on the results of this study, Maru Therapeutics plans to begin non-clinical toxicity testing to enter clinical trials....Maru Therapeutics plans to announce the results of this animal test at the American Association for Cancer Research (AACR 2024) held in San Diego, USA on April 5."

Preclinical • Brain Cancer • CNS Tumor • Glioblastoma • Glioma • Oncology • Solid Tumor